277 related articles for article (PubMed ID: 25895714)
1. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid.
Utkewicz MD; Brunetti L; Awad NI
Am J Emerg Med; 2015 Sep; 33(9):1329.e5-7. PubMed ID: 25895714
[No Abstract] [Full Text] [Related]
2. Tranexamic Acid for Epistaxis--A Promising Treatment That Deserves Further Study.
Clinkard D; Barbic D
CJEM; 2016 Jan; 18(1):72-3. PubMed ID: 26088087
[TBL] [Abstract][Full Text] [Related]
3. Does Oral or Topical Tranexamic Acid Control Bleeding From Epistaxis?
Bridwell RE; April MD; Long B
Ann Emerg Med; 2019 Aug; 74(2):300-302. PubMed ID: 31060746
[No Abstract] [Full Text] [Related]
4. [Nosebleed in new oral anticoagulant treatment - what should be done?].
Stiefelhagen P
MMW Fortschr Med; 2015 Sep; 157(15):25. PubMed ID: 26349711
[No Abstract] [Full Text] [Related]
5. Direct oral anticoagulants and the bleeding patient.
Wood B; Sholzberg M; Ackery A
CMAJ; 2016 Feb; 188(3):215. PubMed ID: 26464134
[No Abstract] [Full Text] [Related]
6. Evaluating three hundred and fifty-two admissions and predictors of re-admissions for epistaxis - is it time to re-evaluate tranexamic acid in epistaxis?
Jervis S; Saunders T; Belcher J; Skinner D
Clin Otolaryngol; 2017 Apr; 42(2):439-442. PubMed ID: 26681525
[No Abstract] [Full Text] [Related]
7. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
[TBL] [Abstract][Full Text] [Related]
8. Is topical tranexamic acid a better alternative for selected cases of anterior epistaxis management in the ED?
Hassen GW; Clemons P; Kaplun M; Kalantari H
Am J Emerg Med; 2018 Apr; 36(4):734.e1-734.e2. PubMed ID: 29310981
[TBL] [Abstract][Full Text] [Related]
9. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial.
Zahed R; Moharamzadeh P; Alizadeharasi S; Ghasemi A; Saeedi M
Am J Emerg Med; 2013 Sep; 31(9):1389-92. PubMed ID: 23911102
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis.
Lacout A; Marcy PY; El Hajjam M; Lacombe P
Cutis; 2013 Apr; 91(4):173-4. PubMed ID: 23763075
[No Abstract] [Full Text] [Related]
11. [Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis].
Pérez del Molino A; Zarrabeitia R; Fernández A; Botella LM
Med Clin (Barc); 2004 Jun; 123(3):118-9. PubMed ID: 15225479
[No Abstract] [Full Text] [Related]
12. BET 1: Tranexamic acid in epistaxis: who bloody nose?
Penrose N; May G
Emerg Med J; 2016 Nov; 33(11):823-825. PubMed ID: 28319931
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid in epistaxis: a systematic review.
Kamhieh Y; Fox H
Clin Otolaryngol; 2016 Dec; 41(6):771-776. PubMed ID: 26946067
[TBL] [Abstract][Full Text] [Related]
14. Topical Tranexamic Acid for the Treatment of Acute Epistaxis: A Systematic Review and Meta-analysis.
Gottlieb M; DeMott JM; Peksa GD
Ann Pharmacother; 2019 Jun; 53(6):652-657. PubMed ID: 30577703
[TBL] [Abstract][Full Text] [Related]
15. The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial.
Reuben A; Appelboam A; Stevens KN; Vickery J; Ewings P; Ingram W; Jeffery AN; Body R; Hilton M; Coppell J; Wainman B; Barton A
Ann Emerg Med; 2021 Jun; 77(6):631-640. PubMed ID: 33612282
[TBL] [Abstract][Full Text] [Related]
16. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
Flanagan BA; Collins C; Parra S
Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Review and Meta-analysis of the Effects of Topical Tranexamic Acid
Li T; Li F; Cha X; Wang S; Yan J; Wang T; Liang C; Zhuang C; Ren W; Liu H
Curr Pharm Des; 2023; 29(19):1497-1503. PubMed ID: 36786144
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic Acid Failed to Reverse the Anticoagulant Effect and Bleeding by an Oral Direct Factor Xa Inhibitor Edoxaban.
Honda Y; Furugohri T; Morishima Y
Pharmacology; 2018; 101(1-2):92-95. PubMed ID: 29131074
[TBL] [Abstract][Full Text] [Related]
19. Best evidence topic reports. BET 3: Topical intranasal tranexamic acid for spontaneous epistaxis.
Hilton L; Reuben A
Emerg Med J; 2014 May; 31(5):436-7. PubMed ID: 24846097
[TBL] [Abstract][Full Text] [Related]
20. Topical tranexamic acid (TXA) for the management of a bleeding arteriovenous fistula.
Eberle ML; Schechter-Perkins EM; Altawil Z
Am J Emerg Med; 2020 Feb; 38(2):407.e5-407.e6. PubMed ID: 31685307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
